Medindia
Advertisement

Leprosy Cases In Morocco Show a Decrease: Study

by Rishika Gupta on December 21, 2018 at 11:08 PM

 Leprosy Cases In Morocco Show a Decrease: Study
Leprosy Cases In Morocco Show a Decrease After Implementation Of Rifampicin Regimen as a preventative measure. Since 2012, the number of cases of leprosy in Morocco has declined by more than 16 percent per year. The results of this study are published in the journal of PLOS Neglected Tropical Diseases.

Leprosy is a chronic infectious disease, affecting mainly the skin and peripheral nerves, which can lead to severe disability. Since antibacterial multidrug therapy against leprosy was introduced in 1981, the number of cases of leprosy worldwide has plummeted.
Advertisement


To fully interrupt transmission in countries such as Morocco, however, additional control efforts are needed. In 2012, Morocco introduced a program to administer Single Dose Rifampicin Chemoprophylaxis (SDRC) to stop the spread of leprosy between household contacts.

In the new work, Ibtissam Khoudri of Morocco's Ministry of Health and colleagues analyzed the leprosy cases detected in Morocco each year between 2000 and 2017. Data on leprosy patients--including age, gender, origin, region, and grade of disability--was included.
Advertisement

Between 2000 and 2012, the annual percent change of leprosy cases was -4.68% per year. However, after the implementation of SDRC, between 2012 and 2017, the annual percent change was -16.83% per year.

In particular, the number of cases decreased more quickly after 2012 in men, children, ten specific regions, and in both urban and rural areas. During the last five years, an average of just 26 new cases per year were detected.

"This time series can be of interest for the medical community as the authors analyze the trends in leprosy in the last 17 years and try to generate a hypothesis about any relationship with chemoprophylaxis implementation," the researchers say.

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Stroop Effect
Plant-Based Diet may Reduce the Risk of COVID-19
Lower Respiratory Tract Infections Linked to Obstructive Sleep Apnea in Children
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Leprosy Amyotrophic Lateral Sclerosis (ALS) Acute Coronary Syndrome 

Recommended Reading
Rifampicin: New Anti-Wolbachia Drug Regimen Changes Therapeutic Approach For Parasitic Helminth Diseases
Rifampicin antibiotic is a new anti-wolbachia drug that was found to change the therapeutic ......
New Naturally Occurring Antibiotic May Help Fight Against Drug-resistant Tuberculosis
Kanglemycin A, a naturally occurring antibiotic found effective against Mycobacterium tuberculosis...
'Survival Gene' Suppresses Mutation Rates in Tuberculosis Bacteria
A key 'survival gene' that prevents strains of tuberculosis (TB) from mutating into drug-resistant ....
Acute Coronary Syndrome
Acute coronary syndrome (ACS) is a sudden, acute life-threatening condition caused by a dramatic red...
Amyotrophic Lateral Sclerosis (ALS)
Find out more about the degenerative disease- Amyotrophic lateral sclerosis....
Leprosy
Leprosy, caused by Mycobacterium leprae, affects any organ like skin, eyes, mucosa, periphery nerves...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use